Updated:
Alivia Analytics
Alivia Analytics builds machine learning tools that stop healthcare fraud before claims are paid, serving Medicaid agencies and commercial plans.
Alivia Analytics
Alivia Analytics occupies a narrow, deeply technical wedge of healthcare finance: the detection and prevention of improper payments in government and commercial health plans. Founded by Eric G. Janoff, the firm builds software that ingests claims data and flags anomalies — phantom billing, upcoding, duplicate claims, and more — before money leaves the door. Its platform integrates directly with payer adjudication systems, a deployment preference that embeds it within clients' real-time claims flow rather than operating as a retrospective audit tool. The firm targets the full spectrum of payment integrity domains — medical, pharmacy, and dental claims — applying machine learning models trained on payer-specific data patterns. Alivia's reference architecture processes structured claims data alongside unstructured clinical notes, lab results, and provider credential files, a data fusion approach that surfaces fraud signals invisible to rules-only engines. The company has secured contracts with multiple state Medicaid agencies and commercial health plans, though it does not publicly disclose a full client roster. Confirmed deployments include work with a large Northeastern Blue Cross Blue Shield plan and the State of Alabama's Medicaid program. Alivia operates from Woburn, Massachusetts, with a lean organizational footprint typical of vertical SaaS businesses serving government health IT. The firm does not publish headcount or total capital deployed. Its product line includes an advanced provider screening module that draws on exclusion lists, licensing board actions, and adverse media to build risk profiles on ordering and billing providers across networks. Alivia does not maintain a venture studio, philanthropic arm, or adjacent investment vehicle, and it does not participate in club-deal co-investment structures common among family offices. Its posture is that of a specialized technology provider, not a capital allocator. The structural differentiator is Alivia's pre-payment orientation. Most payment integrity vendors perform post-payment recovery, taking a contingency fee on clawed-back dollars — a model that preserves the very leakage it claims to fight. Alivia intervenes upstream, stopping improper payments at the point of adjudication. That architecture aligns its incentives with payers' true interest: never losing the money in the first place.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Woburn
Corporate office
Woburn, MA, United States
Principals
Eric G. Janoff
President
Sector focus
Frequently asked questions
Who runs investment decisions at Alivia Analytics?
Alivia Analytics is an operating company, not an investment firm. It does not allocate third-party capital or manage a portfolio of direct investments. Eric G. Janoff serves as President and leads the company's strategic direction. The firm has not publicly disclosed a formal investment committee or announced external capital raises beyond venture backing.
How does Alivia Analytics source proprietary deal flow?
The concept of 'deal flow' does not apply here. Alivia Analytics is a healthcare technology company, not a family office or fund. Its 'pipeline' consists of government RFPs and enterprise sales cycles with commercial health plans. The firm competes against other payment integrity vendors such as Cotiviti and HMS in the procurement process.
Is Alivia Analytics structured as a single family office or does it operate more like a venture firm?
Neither. Alivia Analytics is a private operating company that sells software to healthcare payers. It does not manage family wealth, invest in startups, or operate as a fund. The entity is occasionally misclassified in business registries due to its 'Inc.' suffix and small private-company footprint, but its business model is purely that of a B2B SaaS company.
What is Alivia Analytics' known posture on co-investments alongside external GPs?
Alivia does not co-invest alongside general partners. The firm does not maintain a balance sheet for principal investments, nor does it participate in limited partner co-investment programs. It is a technology vendor, and any capital raised from venture investors has been deployed into product development and go-to-market operations, not into portfolio assets.
Which sectors does Alivia Analytics explicitly avoid?
Alivia is exclusively focused on healthcare payment integrity and does not apply its machine learning tools to other industries. The firm does not work in property and casualty insurance fraud, banking anti-money laundering, or government tax collection. Its data models are purpose-built for medical, pharmacy, and dental claim schemas and do not generalize to other transactional domains.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: